Homoharringtonine (HHT) plus cytarabine (Ara-C) for chronic myeloid leukemia in accelerated phase (CML-AP).

被引：0
作者：
Maloisel, F
De Sarrazin, A
Fohrer, C
Rousselot, P
Maisonneuve, H
Lucas, P
Campos, F
Dufour, P
Bergerat, JP
机构：
[1] Hop Civil, Dept Hematol & Oncol, Strasbourg, France
[2] Hop St Louis, Paris, France
[3] CHD, La Roche Sur Yon, France
[4] Polyclin Les Bleuets, Reims, France
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4778
引用
收藏
页码：262B / 262B
页数：1
相关论文
共 50 条
[41]   A phase I study of Gleevec (imatinib mesylate) administered concomitantly with cytosine arabinoside (Ara-C) in patients with Philadelphia positive chronic myeloid leukemia (CML). [J].
Druker, BJ ;
Kantarjian, HM ;
Talpaz, M ;
Paquette, R ;
Mauro, MJ ;
Rosamilia, M ;
Zoellner, U ;
Resta, D ;
Capdeville, R ;
Sawyers, CL .
BLOOD, 2001, 98 (11) :845A-846A
[42]   Carboplatin (CBDCA) plus cytarabine (ARA-C) in the treatment of high-risk acute myeloblastic leukemia [J].
Larrea, L ;
Martin, G ;
Sanz, GF ;
Martinez, JA ;
Arnao, M ;
Jarque, I ;
Jimenez, C ;
Sanz, MA .
BLOOD, 1996, 88 (10) :856-856
[43]   Induction Therapy by Ara-C Plus Daunorubicin Versus Ara-C plus Gemtuzumab Ozogamicin: Interim Analysis of a Randomized Phase II Trial of the SAL In Elderly Patients with Acute Myeloid Leukemia [J].
Brunnberg, Uta ;
Mohr, Michael ;
Noppeney, Richard ;
Duerk, Heinz A. ;
Sauerland, Maria Cristina ;
Mueller-Tidow, Carsten ;
Krug, Utz O. ;
Koschmieder, Steffen ;
Kessler, Torsten ;
Mesters, Rolf M. ;
Schulz, Christiane ;
Buchner, Thomas ;
Ehninger, Gerhard ;
Duehrsen, Ulrich ;
Serve, Hubert ;
Berdel, Wolfgang E. .
BLOOD, 2010, 116 (21) :152-152
[44]   Imatinib (STI571, Gleevec™) achieves prolonged survival in patients with accelerated phase Ph plus chronic myeloid leukemia (CML-AP):: Up to 36 months follow-up of a phase II study. [J].
Talpaz, M ;
Silver, RT ;
Druker, BJ ;
Paquette, R ;
Goldman, JM ;
Gambacorti-Passerini, C ;
Guilhot, F ;
Schiffer, CA ;
Fischer, T ;
O'Brien, SG ;
Deininger, MW ;
Hochhaus, A ;
Ottmann, OG ;
Gratwohl, A ;
Tura, S ;
Baccarani, M ;
Stone, RM ;
Reiffers, J ;
Bolton, AE ;
Gathmann, I .
BLOOD, 2002, 100 (11) :163A-163A
[45]   PHASE I-II STUDY OF IDARUBICIN AND CYTARABINE (ARA-C) IN ACUTE-LEUKEMIA [J].
BERMAN, E ;
ARLIN, Z ;
DAGHESTANI, A ;
GEE, T ;
KEMPIN, S ;
MERTELSMANN, R ;
ANDREEF, M ;
HANCOCK, C ;
BARATZ, R ;
WILLIAMS, L ;
CLARKSON, B ;
YOUNG, C .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR) :187-187
[46]   Imatinib (Gleevec®) and cytarabine (Ara-C) is an effective regimen in Philadelphia (Ph)-positive chronic myelogenous leukaemia (CML) chronic phase (CP) patients (pts). [J].
Gardembas, M ;
Rousselot, P ;
Tulliez, M ;
Vigier, M ;
Buzyn, A ;
Rigal-Huguet, F ;
Legros, L ;
Michallet, M ;
Berthou, C ;
Najman, A ;
Maloisel, F ;
Mahon, FX ;
Facon, T ;
Berthaud, P ;
Guilhot, J ;
Guilhot, F .
BLOOD, 2002, 100 (11) :95A-95A
[47]   A PHASE-II STUDY OF MITOXANTRONE AND HIGH-DOSE ARA-C (HD ARA-C) IN RELAPSED ACUTE-LEUKEMIA AND BLAST CRISIS OF CHRONIC MYELOGENOUS LEUKEMIA (CML-BC) [J].
WALTERS, R ;
KANTARJIAN, H ;
KEATING, M ;
MCCREDIE, K ;
ESTEY, E ;
BERAN, M ;
ANDERSSON, B ;
FREIREICH, E .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 :195-195
[48]   Autophagy induction of Acute Myeloid Leukemia (AML) cells after treatment with low dose-cytarabine (Ara-C) and enhanced cytocidal effect on AML cells by combined treatment with ara-c plus lenograstim [J].
Tang, Yongmin ;
Li, Lixia ;
Wang, Di ;
Shen, Hongqiang ;
Qian, Baiqin ;
Luo, Chunfang ;
Zhang, Haizhong .
BLOOD, 2007, 110 (11) :114B-114B
[49]   LOW-DOSES OF ARA-C IN CHRONIC MYELOID-LEUKEMIA IN BLASTIC TRANSFORMATION [J].
DIRAIMONDO, F ;
GUGLIELMO, P ;
MILONE, G ;
CACCIOLA, E ;
GIUSTOLISI, R .
HAEMATOLOGICA, 1985, 70 (03) :275-276
[50]   Induction Treatment of Acute Myeloid Leukemia in an Elderly Patient With Intra-marrow Injection of Cytarabine (Ara-C) [J].
Islam, Anwarul .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 :S293-S293
12345